SCHEMBL9546065

SCHEMBL9546065

CC(C)(C)[Si](C)(C)OCCCC(/C=C/C=O)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DUT P33316 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9546068 1.00 DUT (0.33) DUT
SCHEMBL9425960 0.81 DUT (0.34) DUT
SCHEMBL9045350 0.80 DUT (0.35) DUT
SCHEMBL19419906 0.75 TSHR (0.32)
SCHEMBL9425765 0.74 DUT (0.37) DUT
SCHEMBL20573300 0.72 DUT (0.36) DUT
SCHEMBL12770692 0.72 DUT (0.36) DUT
SCHEMBL9158400 0.72
SCHEMBL9158389 0.72
SCHEMBL18940922 0.71 DUT (0.35) DUT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5216183-A Antitumor, anticarcinogenic agents; bone formation accelerators TEIJIN LIMITED (JP) 1993-06-01 US disclosed
EP-0338796-B1 2-SUBSTITUTED-2-CYCLOPENTENONES TEIJIN LIMITED (JP) 1993-03-10 EP disclosed
US-5116869-A Antitumor Agents, Bone Formation Accelerator TEIJIN LIMITED (JP) 1992-05-26 US disclosed
EP-0338796-A2 2-Substituted-2-cyclopentenones TEIJIN LIMITED (JP) 1989-10-25 EP disclosed